Eliem Therapeutics Profit Margin 2021-2024 | CLYM
Current and historical gross margin, operating margin and net profit margin for Eliem Therapeutics (CLYM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Eliem Therapeutics net profit margin as of June 30, 2024 is 0%.
Eliem Therapeutics Annual Profit Margins |
Eliem Therapeutics Quarterly Profit Margins |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.342B |
$0.000B |
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|